HANNAH BRENDAN (Chief Business Officer) exercised options at QUINCE THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/5/2024ACC: 0001415889-24-015533
Officer· Chief Business Officer
Since May 2022
0.00
Net shares
Net seller
$30.8K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
56.06K acquired · 56.06K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+56.06K
Price / share
$0.55
Trade value
$30.83K
% of position
27.8%
6/4/2024
201.56K→257.62K
Total
Net shares
+56.06K
Net value
$30.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2024 | M · Option Exercise | +56.06K | $0.55 | $30.83K | 27.8% | 201.56K | 257.62K |
| Total | +56.06K | $30.83K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
56.06K shares
Shares
−56.06K
Strike price
0.55
Held after
47.44K
Exercisable
—
6/4/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock56.06K shares | 6/4/2024 | M · Option Exercise | −56.06K | 0.55 | — | 47.44K |